OriGene Antibodies in recent publications
Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas Blood, Mar 2013; 121: 2563 - 2566.
Regulation of the PI3-K/Akt Survival Pathway in the Rat Endometrium Biol Reprod, Mar 2013; 88: 79.
RNA elements directing in vivo assembly of the 7SK/MePCE/Larp7 transcriptional regulatory snRNP Nucleic Acids Res., Mar 2013; 10.1093/nar/gkt159.
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements Haematologica, Mar 2013; 98: 404 - 408.
View All Citations >>
Home All anti-KRT17 antibodies
Anti-KRT17 Antibody EPR1624Y
Also for KRT17 (NM_000422)
Homo sapiens keratin 17 (KRT17)
K17; PC; PC2; PCHC1
A synthetic peptide corresponding to residues on the C-terminus of human CK-17 was used as an immunogen.
50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.
WB, IHC, IF
WB: 1: 10,000; IHC: 1:50 100; ICC: 1:50 100; IP: 1:30
This gene encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in this gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex. [provided by RefSeq].
EGFR1 Signaling Pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis on HeLa cell lysate using anti-CK-17 RabMAb (TA303576), dilution 1:10,000.
Immunohistochemical analysis of paraffin-embedded human squamous cervical carcinoma using anti-CK-17 RabMAb (TA303576).
Immunofluorescent staining of A431 cells using anti-CK-17 RabMAb (TA303576).